Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.

Xu D, Wang HW, Yan XL, Li J, Wang K, Xing BC.

Eur J Surg Oncol. 2019 Mar 9. pii: S0748-7983(19)30335-X. doi: 10.1016/j.ejso.2019.03.010. [Epub ahead of print]

PMID:
30879931
2.

Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

Ayez N, Lalmahomed ZS, Eggermont AM, Ijzermans JN, de Jonge J, van Montfort K, Verhoef C.

Ann Surg Oncol. 2012 May;19(5):1618-27. doi: 10.1245/s10434-011-2114-4. Epub 2011 Oct 18.

3.

Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.

Tranchart H, Chirica M, Faron M, Balladur P, Lefevre LB, Svrcek M, de Gramont A, Tiret E, Paye F.

World J Surg. 2013 Nov;37(11):2647-54. doi: 10.1007/s00268-013-2186-3.

PMID:
23982776
4.

Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.

Sasaki K, Margonis GA, Andreatos N, Wilson A, Weiss M, Wolfgang C, Sergentanis TN, Polychronidis G, He J, Pawlik TM.

Br J Surg. 2017 Jun;104(7):926-935. doi: 10.1002/bjs.10510. Epub 2017 Mar 7.

PMID:
28266705
5.

Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.

Pandanaboyana S, White A, Pathak S, Hidalgo EL, Toogood G, Lodge JP, Prasad KR.

Ann Surg Oncol. 2015 Jan;22(1):173-9. doi: 10.1245/s10434-014-3953-6. Epub 2014 Aug 2.

PMID:
25084766
6.

Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.

Margonis GA, Sasaki K, Kim Y, Samaha M, Buettner S, Amini N, Antoniou E, Pawlik TM.

J Gastrointest Surg. 2016 Nov;20(11):1821-1829. Epub 2016 Jul 6.

PMID:
27384430
7.

The Prognostic Impact of Determining Resection Margin Status for Multiple Colorectal Metastases According to the Margin of the Largest Lesion.

Sasaki K, Margonis GA, Maitani K, Andreatos N, Wang J, Pikoulis E, He J, Wolfgang CL, Weiss M, Pawlik TM.

Ann Surg Oncol. 2017 Sep;24(9):2438-2446. doi: 10.1245/s10434-017-5904-5. Epub 2017 Jul 10.

PMID:
28695393
8.

Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.

Laurent C, Adam JP, Denost Q, Smith D, Saric J, Chiche L.

World J Surg. 2016 May;40(5):1191-9. doi: 10.1007/s00268-016-3404-6.

PMID:
26757718
9.

The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.

Wang K, Xu D, Yan XL, Poston G, Xing BC.

Eur J Surg Oncol. 2018 Jun;44(6):771-777. doi: 10.1016/j.ejso.2018.02.210. Epub 2018 Mar 2.

PMID:
29580735
10.

Interaction of margin status and tumour burden determines survival after resection of colorectal liver metastases: A retrospective cohort study.

Mao R, Zhao JJ, Bi XY, Zhang YF, Li ZY, Zhou JG, Zhao H, Cai JQ.

Int J Surg. 2018 May;53:371-377. doi: 10.1016/j.ijsu.2017.12.001. Epub 2017 Dec 8.

PMID:
29229309
11.

Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN.

Ann Surg. 2013 Jun;257(6):1079-88. doi: 10.1097/SLA.0b013e318283a4d1.

12.

R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.

Tanaka K, Nojiri K, Kumamoto T, Takeda K, Endo I.

Eur J Surg Oncol. 2011 Apr;37(4):336-43. doi: 10.1016/j.ejso.2011.01.007. Epub 2011 Jan 31.

PMID:
21277151
13.

The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases.

Wang J, Margonis GA, Amini N, Andreatos N, Yuan C, Damaskos C, Antoniou E, Garmpis N, Buettner S, Barbon C, Deshwar A, He J, Burkhart R, Pawlik TM, Wolfgang CL, Weiss MJ.

J Gastrointest Surg. 2018 Aug;22(8):1350-1357. doi: 10.1007/s11605-018-3748-3. Epub 2018 Apr 9.

PMID:
29633114
14.

Intraoperative surgical margin re-resection for colorectal liver metastasis: is it worth the effort?

Margonis GA, Spolverato G, Kim Y, Ejaz A, Pawlik TM.

J Gastrointest Surg. 2015 Apr;19(4):699-707. doi: 10.1007/s11605-014-2710-2. Epub 2014 Dec 2.

PMID:
25451734
15.

R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R.

Ann Surg. 2008 Oct;248(4):626-37. doi: 10.1097/SLA.0b013e31818a07f1.

PMID:
18936576
16.

Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.

John SK, Robinson SM, Rehman S, Harrison B, Vallance A, French JJ, Jaques BC, Charnley RM, Manas DM, White SA.

Dig Surg. 2013;30(4-6):293-301. doi: 10.1159/000354310. Epub 2013 Aug 21.

PMID:
23969407
17.

The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.

Ardito F, Panettieri E, Vellone M, Ferrucci M, Coppola A, Silvestrini N, Arena V, Adducci E, Capelli G, Vecchio FM, Giovannini I, Nuzzo G, Giuliante F.

Surgery. 2019 Apr;165(4):712-720. doi: 10.1016/j.surg.2018.09.005. Epub 2018 Oct 25.

PMID:
30482518
18.

Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.

Passot G, Chun YS, Kopetz SE, Overman MJ, Conrad C, Aloia TA, Vauthey JN.

Eur J Surg Oncol. 2016 Sep;42(9):1378-84. doi: 10.1016/j.ejso.2016.02.249. Epub 2016 Mar 5.

19.

Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases.

Miller CL, Taylor MS, Qadan M, Deshpande V, Worthington S, Smalley R, Collura C, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Parikh AR, Berger D, Tanabe KK, Lillemoe KD, Ferrone CR.

J Gastrointest Surg. 2017 Nov;21(11):1831-1840. doi: 10.1007/s11605-017-3557-0. Epub 2017 Sep 7.

PMID:
28884391
20.

Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.

Depypere L, Moons J, Lerut T, De Hertogh G, Peters C, Sagaert X, Coosemans W, Van Veer H, Nafteux P.

Dis Esophagus. 2018 Feb 1;31(2). doi: 10.1093/dote/dox117.

PMID:
29036407

Supplemental Content

Support Center